Laurion Capital Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-116,847
| Closed | -$64.3K | – | 452 |
|
|
2023
Q4 | $64.3K | Sell |
116,847
-22,413
| -16% | -$12.3K | ﹤0.01% | 235 |
|
|
2023
Q3 | $294K | Sell |
139,260
-3,640
| -3% | -$7.68K | ﹤0.01% | 179 |
|
|
2023
Q2 | $374K | Hold |
142,900
| – | – | ﹤0.01% | 206 |
|
|
2023
Q1 | $454K | Hold |
142,900
| – | – | ﹤0.01% | 170 |
|
|
2022
Q4 | $384K | Hold |
142,900
| – | – | ﹤0.01% | 161 |
|
|
2022
Q3 | $416K | Hold |
142,900
| – | – | ﹤0.01% | 198 |
|
|
2022
Q2 | $417K | Buy |
+142,900
| New | +$417K | 0.01% | 232 |
|